BioNTech SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,675	9,762	11,664	13,875	1,693
Short-Term Investments	7,202	7,022	4,885	189.4	381.6
Cash & Short-Term Investments	14,877	16,784	16,549	14,065	2,074
Cash Growth	-11.36%	1.42%	17.66%	578.04%	53.95%
Accounts Receivable	924.2	1,464	2,156	7,146	12,382
Other Receivables	8.1	10	4.9	-	-
Total Trade Receivables	932.3	1,474	2,161	7,146	12,382
Inventory	110.7	283.3	357.7	439.6	502.5
Other Current Assets	226.4	262.7	460	272.3	113.8
Total Current Assets	16,147	18,804	19,527	21,922	15,072
Net Property, Plant & Equipment	1,291	1,183	971.6	821.1	520.4
Other Intangible Assets	1,606	790.4	804.1	158.5	202.4
Goodwill	367.9	380.6	362.5	61.2	-
Long-Term Investments	2,554	1,254	1,176	80.2	21.3
Other Long-Term Assets	22.8	117.8	164.7	236.1	14.4
Total Assets	21,989	22,530	23,006	23,279	15,831
Accounts Payable	534.9	426.7	354	204.1	160
Accrued Expenses	145.3	144.8	269.3	367.2	110.2
Current Portion of Leases	52.2	39.5	28.1	36	129.9
Unearned Revenue	754.9	294.9	353.3	101.5	276.1
Other Current Liabilities	655	1,617	1,066	2,242	2,805
Total Current Liabilities	2,142	2,523	2,071	2,951	3,482
Long-Term Leases	215.2	214.7	191	176.2	171.6
Other Long-Term Liabilities	406.9	380.7	498.9	96.7	283.9
Total Long-Term Liabilities	622.1	595.4	689.9	272.9	455.5
Total Liabilities	2,764	3,119	2,760	3,224	3,937
Common Stock	259	248.6	248.6	248.6	246.3
Treasury Stock	-7.7	-8.6	-10.8	-5.3	-3.8
Additional Paid-in Capital	2,473	1,399	1,229	1,828	1,674
Accumulated Other Comprehensive Income	-1,462	-1,326	-984.6	-848.9	93.9
Retained Earnings	17,962	19,098	19,763	18,833	9,883
Shareholders' Equity	19,224	19,411	20,246	20,056	11,894
Total Liabilities & Equity	21,989	22,530	23,006	23,279	15,831
Total Debt	267.4	254.2	219.1	212.2	301.5
Net Cash (Debt)	14,610	16,529	16,330	13,852	1,773
Net Cash Growth	-11.61%	1.22%	17.89%	681.38%	60.10%
Net Cash Per Share	60.45	68.76	67.28	55.45	6.83
Book Value	19,224	19,411	20,246	20,056	11,894
Book Value Per Share	79.54	80.75	83.42	80.29	45.80
Tangible Book Value	17,250	18,240	19,079	19,836	11,691
Tangible Book Value Per Share	71.37	75.87	78.61	79.41	45.02

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.